Tetrahydroberberine, an isoquinoline alkaloid isolated from corydalis tuber, enhances gastrointestinal motor function

Journal of Pharmacology and Experimental Therapeutics

Volumn 338, Issue 3, 2011, Pages 917-924

  Lee, Tae Ho ^a   Kim, Ki Hyun ^b   Lee, Sung Ok ^b   Lee, Kang Ro ^b   Son, Miwon ^a   Jin, Mirim ^c  

^a Dong A Pharmaceutical Company   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Daejeon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CANADINE; DOPAMINE 2 RECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N(G) NITROARGININE METHYL ESTER; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORYDALIS; CORYDALIS TUBER; DOG; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG ISOLATION; ELECTROMYOGRAPHY; GASTROINTESTINAL TRACT FUNCTION; HUMAN; HUMAN CELL; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; STOMACH EMPTYING;

ANIMALS; BERBERINE; BINDING, COMPETITIVE; CHO CELLS; CORYDALIS; CRICETINAE; CRICETULUS; DOGS; DYSPEPSIA; ELECTROMYOGRAPHY; GASTRIC FUNDUS; GASTROINTESTINAL MOTILITY; HEK293 CELLS; HUMANS; MALE; MUSCLE RELAXATION; PLANT EXTRACTS; PLANT ROOTS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL;

EID: 80052143482     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.182048     Document Type: Article

References (46)

1. Blancquaert JP, Lefebvre RA, and Willems JL (1982) Gastric relaxation by intravenous and intracerebroventricular administration of apomorphine, morphine and fentanyl in the conscious dog. Arch Int Pharmacodyn Ther 256:153-154. (Pubitemid 12145663)
2. Boess FG, Steward LJ, Steele JA, Liu D, Reid J, Glencorse TA, and Martin IL (1997) Analysis of the ligand binding site of the 5-HT3 receptor using site directed mutagenesis: importance of glutamate 106. Neuropharmacology 36:637-647. (Pubitemid 27272109)
3. Brun R and Kuo B. (2010) Functional dyspepsia. Therap Adv Gastroenterol 3:145-164.
4. Chen J, Koothan T, and Chen JD (2009) Synchronized gastric electrical stimulation improves vagotomy-induced impairment in gastric accommodation via the nitrergic pathway in dogs. Am J Physiol Gastrointest Liver Physiol 296:G310-G318.
5. Coulie B, Tack J, Sifrim D, Andrioli A, and Janssens J (1999) Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am J Physiol 276:G373-G377. (Pubitemid 29104150)
6. De Maeyer JH, Lefebvre RA, and Schuurkes JA (2008) 5-HT4 receptor agonists: similar but not the same. Neurogastroenterol Motil 20:99-112.
7. Degen L, Matzinger D, Merz M, Appel-Dingemanse S, Osborne S, Lüchinger S, Bertold R, Maecke H, and Beglinger C (2001) Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 15:1745-1751. (Pubitemid 33001138)
8. Desai KM, Sessa WC, and Vane JR (1991) Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 351:477-479. (Pubitemid 21896622)
9. Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, Knowles MR, and McAllister G (1994) Expression and pharmacological characterization of the human D3 dopamine receptor. J Pharmacol Exp Ther 268:417-426. (Pubitemid 24039117)
10. Gommeren WR, Van Gompel P, Lesage A, Leysen JE, and Jurzak M (1998) Extensive pharmacological study of the G-protein coupled fraction of human 5-HT receptors using agonist radioligand binding. Naunyn Schmiedebergs Arch Pharmacol 358: R113.
11. Holtmann G, Talley NJ, Liebregts T, Adam B, and Parow C (2006) A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 354:832-840. (Pubitemid 43290921)
12. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
13. Iwanaga Y, Miyashita N, Morikawa K, Mizumoto A, Kondo Y, and Itoh Z (1990) A novel water-soluble dopamine-2 antagonist with anticholinesterase activity in gastrointestinal motor activity. Comparison with domperidone and neostigmine. Gastroenterology 99:401-408. (Pubitemid 20219096)
14. Janssen P, Tack J, Sifrim D, Meulemans AL, and Lefebvre RA (2004) Influence of 5-HT1 receptor agonists on feline stomach relaxation. Eur J Pharmacol 492:259-267. (Pubitemid 38721380)
15. Kakigami T, Usui T, Tsukamoto K, and Kataoka T (1998) Synthesis and structure-activity relationship of 3-Substituted benzamide, benzo [b]furan-7-carboxamide, 2,3-dihydrobenzo[b]furan-77-carboxamide, and indole-5-carboxamide derivatives as selective serotonin 5-HT4 receptor agonists. Chem Pharm Bull 46:42-52.
16. Karamanolis G and Tack J (2006) Promotility medications - now and in the future. Dig Dis 24:297-307. (Pubitemid 44114423)
17. Kindt S and Tack J (2006) Impaired gastric accommodation and its role in dyspepsia. Gut 55:1685-1691. (Pubitemid 44893562)
18. Koek W, Patoiseau JF, Assié MB, Cosi C, Kleven MS, Dupont-Passelaigue E, Carilla-Durand E, Palmier C, Valentin JP, John G, et al. (1998) F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and anti-depressant potential. J Pharmacol Exp Ther 287:266-283. (Pubitemid 29140211)
19. Koizumi HM, Suzuki S, Hirata M, and Sunaga M (1992) Thirteen-week oral toxicity study on HSR-803 with 4-week recovery test in dogs (in Japanese). Preclin Rep Cent Inst Exp Anim 18:65-85.
20. Lee TH, Choi JJ, Kim DH, Choi S, Lee KR, Son M, and Jin M (2008) Gastroprokinetic effects of DA-9701, a new prokinetic agent formulated with Pharbitis Semen and Corydalis Tuber. Phytomedicine 15:836-843.
21. Leysen JE, Gommeren W, Heylen L, Luyten WH, Van de Weyer I, Vanhoenacker P, Haegeman G, Schotte A, Van Gompel P, Wouters R, et al. (1996) Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan. Mol Pharmacol 50:1567-1580.
22. May JA, McLaughlin MA, Sharif NA, Hellberg MR, and Dean TR (2003) Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. J Pharmacol Exp Ther 306:301-309. (Pubitemid 36734385)
23. Mearin F, Rodrigo L, Pérez-Mota A, Balboa A, Jiménez I, Sebastián JJ, and Patón C (2004) Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. Clin Gastroenterol Hepatol 2:301-308. (Pubitemid 38447194)
24. Millan MJ, Seguin L, Honoré P, Girardon S, and Bervoets K (1996) Pro- and antinociceptive actions of serotonin (5-HT)1A agonists and antagonists in rodents: relationship to algesiometric paradigm. Behav Brain Res 73:69-77.
25. Niwa M, Mibu H, Nozaki M, Tsurumi K, and Fujimura H (1991) Dopaminergic unique affinity of tetrahydroberberine and L-tetrahydroberberine-d-camphor sulfonate. Pharmacology 43:329-336.
26. Ozaki A and Sukamoto T (1999) Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist. Gen Pharmacol 33:283-288. (Pubitemid 29376467)
27. Pasricha PJ (2007) Desperately seeking serotonin. . . A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders. Gastroenterology 132:2287-2290.
28. Reddymasu SC, Soykan I, and McCallum RW (2007) Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol 102: 2036-2045. (Pubitemid 47301500)
29. Rukebusch M and Fioramonti J (1975) Electrical spiking activity and propulsion in small intestine in fed and fasted rats. Gastroenterology 68:1500-1508.
30. Stormann TM, Gdula DC, Weiner DM, and Brann MR (1990) Molecular cloning and expression of a dopamine D2 receptor from human retina. Mol Pharmacol 37:1-6. (Pubitemid 20038441)
31. Tack J (2007) Gastric motor disorders. Best Pract Res Clin Gastroenterol 21:633-644.
32. Tack J (2008) Prokinetics and fundic relaxants in upper functional GI disorders. Curr Opin Pharmacol 8:690-696.
33. Tack J, Piessevaux H, Coulie B, Fischler B, De Gucht V, and Janssens J (1999) A placebo-controlled trial of buspirone, a fundus-relaxing drug, in functional dyspepsia: Effect on symptoms and gastric sensory and motor function [abstract]. Gastroenterology 116:G1423.
34. Tack J, Coulie B, Wilmer A, Andrioli A, and Janssens J (2000) Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 46:468-473. (Pubitemid 30305809)
35. Takahashi T and Owyang C (1997) Characterization of vagal pathways mediating gastric accommodation reflex in rats. J Physiol 504:479-488. (Pubitemid 27478421)
36. Talley NJ, Locke GR 3rd, Lahr BD, Zinsmeister AR, Tougas G, Ligozio G, Rojavin MA, and Tack J (2006) Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut 55:933-939. (Pubitemid 43962602)
37. Tonini M, Cipollina L, Poluzzi E, Crema F, Corazza GR, and De Ponti F (2004) Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther 19:379-390. (Pubitemid 38297106)
38. Tonini M and Pace F (2006) Drugs acting on serotonin receptors for the treatment of functional GI disorders. Dig Dis 24:59-69.
39. Tsubouchi T, Saito T, Mizutani F, Yamauchi T, and Iwanaga Y (2003) Stimulatory action of itopride hydrochloride on colonic motor activity in vitro and in vivo. J Pharmacol Exp Ther 306:787-793. (Pubitemid 36886181)
40. Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD, Kralstein J, Earnest DL, Ligozio G, and Cohard-Radice M (2008) Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol 103:1906-1919.
41. Van Oudenhove L, Kindt S, Vos R, Coulie B, and Tack J (2008) Influence of buspirone on gastric sensorimotor function in man. Aliment Pharmacol Ther 28:1326-1333.
42. Wu J and Jin GZ (1996) Tetrahydroberberine suppresses dopamine-induced potassium current in acutely dissociated CA1 pyramidal neurons from rat hippocampus. Neurosci Lett 207:155-158. (Pubitemid 26116552)
43. Wu J and Jin GZ (1997) Tetrahydroberberine blocks membrane K+ channels underlying its inhibition of intracellular message-mediated outward currents in acutely dissociated CA1 neurons from rat hippocampus. Brain Res 775:214-218. (Pubitemid 28020508)
44. Wysowski DK, Corken A, Gallo-Torres H, Talarico L, and Rodriguez EM (2001) Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions. Am J Gastroenterol 96:1698-1703.
45. Yoshikawa T, Yoshida N, Mine Y, and Hosoki K (1998) Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum. Jpn J Pharmacol 77:53-59. (Pubitemid 28263990)
46. Zhou SY, Lu YX, and Owyang C (2008) Gastric relaxation induced by hyperglycemia is mediated by vagal afferent pathways in the rat. Am J Physiol Gastrointest Liver Physiol 294:G1158-G1164.